Research Article

Effect of the Herbal Drug Guilu Erxian Jiao on Muscle Strength, Articular Pain, and Disability in Elderly Men with Knee Osteoarthritis

Table 3

Measurements of muscle strength, VAS, and Lequesne index scores in the GEJ-treated group () before and after 12 weeks of treatment.

VariablesPretreatment Posttreatment
MedianMedian value

Measurements of muscle strength
 PeakTQ-ext-nondominant (Nm)38.8018.2045.9052.1037.9065.300.007**
 PeakTQ-ext-dominant (Nm)29.1019.5049.6051.6040.1062.600.001**
 PeakTQ-flex-nondominant(Nm)19.5014.4032.6020.7019.1036.200.085
 PeakTQ-flex-dominant (Nm)18.8015.7033.2030.8021.7036.700.092
 TQ/BW-ext-nondominant (ft·lb/lb)66.6035.3083.1076.5071.70103.900.006**
 TQ/BW-ext-dominant (ft·lb/lb)57.8027.4082.4087.1058.9099.400.001**
 TQ/BW-flex-nondominant (ft·lb/lb)33.0024.4051.2039.7031.4055.800.092
 TQ/BW-flex-dominant (ft·lb/lb)37.3024.2053.8047.5038.2058.600.076
Measurements of visual analog pain scale score (VAS)
 visual analog pain scale score 2.000.003.000.000.002.000.005**
Measurements of Lequesne index score
 Lequesne index score6.003.009.003.000.006.000.001**
   (I) Pain or discomfort2.001.003.000.000.001.000.003**
   (II) Maximum distance walked1.001.003.001.000.002.000.150
   (III) Activities of daily living2.001.005.001.000.003.000.032*

Wilcoxon signed-rank test; * < 0.05; ** < 0.01.